- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03387202
Laparoscopic Lateral Mesh Suspension for Pelvic Organ Prolapse
Uterine Preserving Apical Prolapse Correction With Laparoscopic Lateral Mesh Suspension: Initial Experience by Defining Anatomic and Subjective Success
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Vaginal length, bladder neck mobility and pelvic floor biometry with anteroposterior hiatal diameter and pelvic organ descent measurements are measured by transperineal ultrasonography to assess anatomic success in the preoperative and at postoperative 18th months if available.
Female Sexual Function Index (FSFI), Michigan Incontinence Severity Index (M-ISI), Prolapse Quality of Life questionnaire (PQoL), Pelvic Organ Prolapse Symptom Score (POP-SS) and Visual Analog Score (VAS) are used to assess subjective success in the preoperative and at postoperative 18th months if available.
,
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- >18 years old symptomatic women with pelvic organ prolapse needing surgery.
- Patients who are not comfortable with using or refusing pessary
- Refusing sacrocolpopexy due to its serious surgical risk
Exclusion Criteria:
- Patients who prefer sacrocolpopexy
- Any cue for gynecologic oncological condition
- Patients who approves Le Fort colpocleisis among who does not have any sexual intercourse
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
pelvic organ prolapse
Participants received "Laparoscopic lateral suspension with mesh" as part of routine medical care in apical prolapse, thus, the investigator does not assign a intervention but studies the effects.Vaginal length, bladder neck mobility and pelvic floor biometry with AP hiatal diameter and pelvic organ descent measurements are measured by Transperineal ultrasound to assess anatomic success in the preoperative and at postoperative 18th months.
POP-Q assessment and translabial usg for objective success; Female Sexual Function Index (FSFI), Michigan Incontinence Severity Index (M-ISI), Prolapse Quality of Life questionnaire (PQoL), Pelvic Organ Prolapse Symptom Score (POP-SS) and Visual Analog Score (VAS) are used to assess subjective success.
|
V-shaped ccm wide and 25cm length mesh strip is prepared from a 30x30cm Prolene mesh (Ethicon J&J).Deep dissection of the uterovesical space is performed.Cutaneous incisions are bilaterally made 3cmsuperoposterior to the anteriosuperior iliac spine.A grasper is introduced retroperitoneally through the subperitoneum holding the beginning part of mesh until reaching the vesicovaginal space in an oblique route rather than transverse.Broad ligament is lifted upward and tunnel is practiced in its lower third.Assistant grasper catches the distal mesh and pulls out through the opposite subperitoneal tunnel.Corner of mesh is fixed to the pubocervical fascia,uterine cervix and isthmus with Absorba Tack™(Covidien, Mansfield,USA).Tension-free lateral mesh suspension is achieved at the desired level
Vaginal length, bladder neck mobility and pelvic floor biometry with anterioposterior hiatal diameter and pelvic organ descent measurements are measured by transperineal ultrasonography to assess anatomic success in the preoperative and at postoperative first third and sixth months if available.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline POP-Q measurements (mm) at 18th month.
Time Frame: 18 months
|
Prolapse degree; Point Ba/C/Bp
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Success - Change from baseline Female Sexual Function Index (FSFI) to measure sexual dysfunction at 18th month.
Time Frame: 18 months
|
Validated into Turkish language form will be used to compare preoperative and postoperative period.
The FSFI is a multiple-trait scoring, self-report document used to assess female SF during the previous 4 weeks.
It consists of 19 items that encompass six separate domains: desire, arousal, lubrication, orgasm, satisfaction, and pain.
The maximum score is 36 points and the minimum score is 2 points.
After completion of the questionnaire, the total SF score was calculated as follows: no sexual dysfunction (SD) (≥ 30 points) , mild SD (between <29 and > 23 points), and severe SD (≤ 22 points).
|
18 months
|
|
Subjective Success - Change from baseline Michigan Incontinence Severity Index (M-ISI) to measure urinary incontinence at 18th month.
Time Frame: 18 months
|
Validated into Turkish language form will be used to compare preoperative and postoperative period.
It has ten items, consisting of a total M-ISI domain (the sum of items 1-8) and a distinct Bother domain (the sum of items 9 and 10).
The total M-ISI score consists of three subdomains (items 1-3 for stress urinary incontinence [SUI], items 4-6 for UUI, and items 7 and 8 for PU).
The responses for each item range from 0 to 4 on a Likert-type scale, with higher values representing greater symptoms and greater bother.
The total M-ISI domain ranges from 0 to 32, the Bother domain ranges from 0 to 8, the SUI and UUI subdomains range from 0 to 12, and the PU subdomain ranges from 0 to 8. Total domain and subdomain scores are obtained by simply adding the respective answers.
The minimally important difference has been determined for the following domains/subdomains: total M-ISI (4 points), SUI (2 points), UUI (2 points), and PU (1 point).
|
18 months
|
|
Subjective Success - Change from baseline Prolapse Quality of Life questionnaire (PQoL) to measure quality of life according to pelvic organ prolapse at 18th month.
Time Frame: 18 months
|
Validated into Turkish language form will be used to compare preoperative and postoperative period.
he questionnaire included 20 questions grouped in sections (domains) related to a particular aspect of quality of life.
A total of nine domains covering general health, prolapse impact, role limitations, physical and social limitations, personal relationships, emotional problems, sleep/energy disturbance as well as severity symptoms measurements were defined.
Questions regarding bladder, bowel and sexual function were also separately included and validated for reproducibility and internal consistency.
Responses ranged from 'none/not at all', through 'slightly/a little' and 'moderately' to 'a lot' to produce a four-point scoring system for each item.
Scores in each domain ranged between 0 and 100 with a high total score indicating a greater impairment of quality of life.
|
18 months
|
|
Subjective Success - Change from baseline Pelvic Organ Prolapse Symptom Score (POP-SS) to measure quality of life according to pelvic organ prolapse at 18th month.
Time Frame: 18 months
|
Validated into Turkish language form will be used to compare preoperative and postoperative period.
Total range scores: 28 (min:0, max:28).
Higher values represent a worse outcome.
|
18 months
|
|
Subjective Success - Change from baseline Visual Analog Score (VAS) for pain at 18th month.
Time Frame: 18 months
|
Participant describes the pain related to the mesh.
The respondent selects a whole number (0-10 integers) that best reflects the intensity of their pain with a format of a horizontal bar.
|
18 months
|
|
Change from baseline Pelvic Hiatus measurements (mm) at 18th month.
Time Frame: 18 months
|
Anteroposterior hiatal length (mm)
|
18 months
|
|
Change from baseline Pelvic biometry measurements at 18th month.
Time Frame: 18 months
|
Prolapse degree over symphysis pubis (mm) Anterior compartment over 10, Posterior compartment over 15 mm are clinically relevant
|
18 months
|
|
Change from baseline bladder neck mobility measurements at 18th month.
Time Frame: 18 months
|
Urethral rotation (degree) between rest and valsalva maneuver states
|
18 months
|
|
Failure (%)
Time Frame: 18 months
|
Failure is defined by any recurrence of prolapse, mesh erosion and need for additional surgery
|
18 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FSM KAEHK
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Organ Prolapse
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse, Patient Education | Pelvic Organ Prolapse (POP)United States
-
Hillel Yaffe Medical CenterCompletedHysterectomy | Pelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse (POP)Israel
-
University of CalgaryAlberta Health services; Cook Group IncorporatedCompletedAnterior Pelvic Organ ProlapseCanada
-
Wolfson Medical CenterRecruiting
-
Queen's UniversityNot yet recruitingPelvic Organ Prolapse (POP)Canada
-
Coloplast A/SCompletedPelvic Organ Prolapse (POP)United States
-
Chung Shan Medical UniversityActive, not recruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Sacrocolpopexy | PectopexyTaiwan
-
A.M.I. Agency for Medical Innovations GmbHActive, not recruitingProlapse | Pelvic Organ Prolapse (POP) | SacrocolpopexyGermany
-
University of British ColumbiaCompletedPelvic Organ Prolapse, Patient EducationCanada
-
University of MelbourneCompletedVaginal Hysterectomy | Pelvic Organ Prolapse Vaginal SurgeryAustralia
Clinical Trials on Laparoscopic lateral suspension with mesh
-
Fatih Sultan Mehmet Training and Research HospitalSisli Hamidiye Etfal Training and Research HospitalCompletedPelvic Organ Prolapse | Pelvic Floor ProlapseTurkey
-
A.M.I. Agency for Medical Innovations GmbHRecruitingLaparoscopic Surgery | Genital Prolapse | Uterus Prolapse | Pelvic Organ Prolapse (POP)Austria, Germany
-
Kanuni Sultan Suleyman Training and Research HospitalRecruiting
-
Fundacion para la Formacion e Investigacion Sanitarias...Recruiting
-
Antalya Training and Research HospitalCompleted
-
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training...CompletedVaginal Vault Prolapse | Pelvic Floor ProlapseTurkey
-
Prof. Dr. Cemil Tascıoglu Education and Research...CompletedPelvic Organ ProlapseTurkey
-
National Cheng-Kung University HospitalRecruitingPelvic Organ Prolapse | Uterine ProlapseTaiwan
-
Peking University People's HospitalActive, not recruiting
-
Catholic University of the Sacred HeartMiulli General HospitalUnknownPelvic Organ ProlapseItaly